Consolidated net gain for the 90 days ended June 30, 2011 was million, or per share, versus $0.15 million or $0.01 per talk about, for the same period this year 2010. Consolidated net gain for the six months ended June 30, 2011 was $0.48 million vs. $0.17 million, for the same period this year 2010. THE BUSINESS had a cash balance of $0.21 as of June 30, as compared with $0.14 million by March 31, 2011.. Akela total consolidated revenues increase to $7.3M for six weeks ended June 30, 2011 Akela Pharma, Inc.Our study started before the recommendations for CPR changed the recommendation from 2 ventilations alternating with 15 compressions to 30 compressions alternating with 2 ventilations. Our instructions of 2 ventilations alternating with 15 compressions had been maintained through the entire scholarly study, since the new guidelines didn’t address dispatcher-assisted CPR. Data were collected from EMS information, and information regarding survival position was collected from national registers. No interrater dependability assessment was performed.